Shandong YaoBo’s controlling shareholder released the pledge of 8.48 million shares
February 5, 2025
Source: drugdu
39
On January 27, Shandong YaoBo (600529) issued an announcement that the controlling shareholder Shandong Luzhong Investment released the pledge of 8.48 million shares, accounting for 6.55% of its shares and 1.28% of the company's total share capital; as of the date of the announcement, Luzhong Investment had pledged a total of 53.8 million shares, accounting for 41.58% of its shares and 8.11% of the company's total share capital.
In the first three quarters of 2024, Shandong YaoBo achieved revenue of 3.825 billion yuan and net profit attributable to the parent of 720 million yuan.
Source: https://finance.eastmoney.com/
By editor
Copyright©2025 Ddu. All rights reserved.
Read more on
- Analysis Report on Import and Export of Medical Devices in China February 7, 2025
- Starting from February 1st, the settlement method for centralized procurement consumables has changed February 7, 2025
- Haisike has been approved to conduct clinical trials of the innovative drug HSK39004 February 7, 2025
- Innovative drugs are expected to accelerate into hospitals, and the Class C medical insurance catalogue is about to be released February 7, 2025
- Keytruda sold $29.5 billion last year, and Merck suspended shipments of HPV vaccines to the Chinese market February 7, 2025
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
